Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Online Pharmacy Bill Introduced, Auguring Ongoing Oversight Debate In 2001

Executive Summary

The introduction of a bipartisan Internet pharmacy bill as the 106th Congress draws to a close indicates that the debate on oversight of online drug sales will likely be revived in 2001.

You may also be interested in...



FDA "Personal Use" Regs Frustrate Internet Pharmacy Oversight - GAO

FDA's inconsistent application of its personal use drug import exemption has frustrated other federal agencies attempting to take action on drugs illegally shipped into the U.S. by foreign Internet pharmacies, a General Accounting Office report says.

FDA "Personal Use" Regs Frustrate Internet Pharmacy Oversight - GAO

FDA's inconsistent application of its personal use drug import exemption has frustrated other federal agencies attempting to take action on drugs illegally shipped into the U.S. by foreign Internet pharmacies, a General Accounting Office report says.

State AGs Need Power To Pursue Online Pharmacies In Federal Court - Bliley

State Attorneys General would be given authority to seek injunctions against companies illegally selling prescription drugs over the Internet in federal court under legislation to be introduced by Commerce Committee Chairman Bliley (R-Va.) and Commerce/Oversight & Investigations Subcommittee Chairman Upton (R-Mich.).

Latest Headlines
See All
UsernamePublicRestriction

Register

PS036786

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel